The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 18, 2015
Filed:
Oct. 26, 2010
Applicants:
Andrew John Cooke, West Point, PA (US);
Emma Louise Carswell, Cambridge, GB;
David Jonathan Bennett, West Point, PA (US);
Inventors:
Andrew John Cooke, West Point, PA (US);
Emma Louise Carswell, Cambridge, GB;
David Jonathan Bennett, West Point, PA (US);
Assignee:
Merck Sharp & Dohme B.V., Haarlem, NL;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/445 (2006.01); C07D 211/28 (2006.01); C07D 295/135 (2006.01); C07D 213/75 (2006.01); C07D 237/20 (2006.01); C07D 239/42 (2006.01); C07D 261/12 (2006.01); C07D 295/096 (2006.01); C07D 295/192 (2006.01);
U.S. Cl.
CPC ...
C07D 295/135 (2013.01); C07D 211/28 (2013.01); C07D 213/75 (2013.01); C07D 237/20 (2013.01); C07D 239/42 (2013.01); C07D 261/12 (2013.01); C07D 295/096 (2013.01); C07D 295/192 (2013.01);
Abstract
The present invention relates to (1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl derivatives having the general formula (I) to pharmaceutical compositions comprising the same and to the use of these (1,1,1,3,3,3-hexafluoro-2-hydroxy-propan-2-yl)phenyl derivatives in the treatment of atherosclerosis.